Metropolitan Health Networks
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Metropolitan Health Networks' revenues will expand 103.3% and EPS will grow 5.9%.
The average estimate for revenue is $197.9 million. On the bottom line, the average EPS estimate is $0.18.
Last quarter, Metropolitan Health Networks reported revenue of $195.2 million. GAAP reported sales were much higher than the prior-year quarter's $94.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.18. GAAP EPS of $0.17 for Q1 were 11% lower than the prior-year quarter's $0.19 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 19.4%, 90 basis points worse than the prior-year quarter. Operating margin was 10.9%, 260 basis points worse than the prior-year quarter. Net margin was 4.1%, 430 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $793.5 million. The average EPS estimate is $0.82.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 219 members out of 231 rating the stock outperform, and 12 members rating it underperform. Among 27 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 25 give Metropolitan Health Networks a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Metropolitan Health Networks is buy, with an average price target of $9.65.
- Add Metropolitan Health Networks to My Watchlist.